U.S. Department of Health and Human Services Awards Kaléo with Contract to Develop Next Generation Organophosphate Nerve Agent Poisoning Countermeasure Richmond, Virginia, April 17, 2024 (GLOBE NEWSWIRE) -- Kaléo, a privately-held U.S. pharmaceutical company today announced their selection by the Biomedical Advanced Research and Development...

AirBoss Defense Group Strengthens Senior Leadership Team JESSUP, Md., Jan. 31, 2022 (GLOBE NEWSWIRE) -- AirBoss Defense Group (ADG) is pleased to announce that it has added significant strength to its senior leadership team following a period of sustained...

AirBoss Defense Group Awarded Contracts Valued at Over $123 Million to Support the PPE Requirements of the U.S. Strategic National Stockpile and the U.S. Department of Veterans Affairs LANDOVER, Md., July 27, 2020 (GLOBE NEWSWIRE) -- AirBoss Defense Group (ADG), which is focused on the design, development and manufacturing of American-made, proven, commercially available personal...

Bavarian Nordic's IMVAMUNE(R) Smallpox Vaccine Highlighted as Success Story in WMD Center's Bio-Response Report Card KVISTGARD, Denmark, Oct. 12, 2011 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (Copenhagan:BAVA) today applauded the release of the WMD Center's Bio-Response Report Card, which concluded that the response...